Plasma Protease C1-inhibitor Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 69 pages | ID: P101C80129B8EN
Market Monitor Global

Abstracts

This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising pipeline drugs and novel therapies, rising investments in innovation of inhibitor drugs and increasing HAE awareness programs are the major drivers of the global plasma protease C1-inhibitors treatment market.

This report contains market size and forecasts of Plasma Protease C1-inhibitor Treatment in Global, including the following market information:

Global Plasma Protease C1-inhibitor Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Plasma Protease C1-inhibitor Treatment market was valued at 3265.3 million in 2021 and is projected to reach US$ 9559.1 million by 2028, at a CAGR of 16.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

C1-inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Plasma Protease C1-inhibitor Treatment include Takeda, CSL, Sanquin and Pharming Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma Protease C1-inhibitor Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Plasma Protease C1-inhibitor Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Plasma Protease C1-inhibitor Treatment Market Segment Percentages, by Type, 2021 (%)

• C1-inhibitors
• Kallikrein Inhibitor (Kalbitor)

Global Plasma Protease C1-inhibitor Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Plasma Protease C1-inhibitor Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Independent Pharmacies and Outlets

Global Plasma Protease C1-inhibitor Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Plasma Protease C1-inhibitor Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Plasma Protease C1-inhibitor Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Plasma Protease C1-inhibitor Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• CSL
• Sanquin
• Pharming Group

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Plasma Protease C1-inhibitor Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Plasma Protease C1-inhibitor Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PLASMA PROTEASE C1-INHIBITOR TREATMENT OVERALL MARKET SIZE

2.1 Global Plasma Protease C1-inhibitor Treatment Market Size: 2021 VS 2028
2.2 Global Plasma Protease C1-inhibitor Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Plasma Protease C1-inhibitor Treatment Players in Global Market
3.2 Top Global Plasma Protease C1-inhibitor Treatment Companies Ranked by Revenue
3.3 Global Plasma Protease C1-inhibitor Treatment Revenue by Companies
3.4 Top 3 and Top 5 Plasma Protease C1-inhibitor Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Plasma Protease C1-inhibitor Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Plasma Protease C1-inhibitor Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Plasma Protease C1-inhibitor Treatment Market Size Markets, 2021 & 2028
  4.1.2 C1-inhibitors
  4.1.3 Kallikrein Inhibitor (Kalbitor)
4.2 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
  4.2.1 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Plasma Protease C1-inhibitor Treatment Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Independent Pharmacies and Outlets
5.2 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
  5.2.1 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Plasma Protease C1-inhibitor Treatment Market Size, 2021 & 2028
6.2 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue & Forecasts
  6.2.1 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028
  6.3.2 US Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.3.3 Canada Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.3.4 Mexico Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028
  6.4.2 Germany Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.3 France Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.4 U.K. Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.5 Italy Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.6 Russia Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.4.8 Benelux Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028
  6.5.2 China Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.5.3 Japan Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.5.4 South Korea Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.5.6 India Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028
  6.6.2 Brazil Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.6.3 Argentina Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028
  6.7.2 Turkey Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.7.3 Israel Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028
  6.7.5 UAE Plasma Protease C1-inhibitor Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda Plasma Protease C1-inhibitor Treatment Major Product Offerings
  7.1.4 Takeda Plasma Protease C1-inhibitor Treatment Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 CSL
  7.2.1 CSL Corporate Summary
  7.2.2 CSL Business Overview
  7.2.3 CSL Plasma Protease C1-inhibitor Treatment Major Product Offerings
  7.2.4 CSL Plasma Protease C1-inhibitor Treatment Revenue in Global Market (2017-2022)
  7.2.5 CSL Key News
7.3 Sanquin
  7.3.1 Sanquin Corporate Summary
  7.3.2 Sanquin Business Overview
  7.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Major Product Offerings
  7.3.4 Sanquin Plasma Protease C1-inhibitor Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sanquin Key News
7.4 Pharming Group
  7.4.1 Pharming Group Corporate Summary
  7.4.2 Pharming Group Business Overview
  7.4.3 Pharming Group Plasma Protease C1-inhibitor Treatment Major Product Offerings
  7.4.4 Pharming Group Plasma Protease C1-inhibitor Treatment Revenue in Global Market (2017-2022)
  7.4.5 Pharming Group Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Plasma Protease C1-inhibitor Treatment Market Opportunities & Trends in Global Market
Table 2. Plasma Protease C1-inhibitor Treatment Market Drivers in Global Market
Table 3. Plasma Protease C1-inhibitor Treatment Market Restraints in Global Market
Table 4. Key Players of Plasma Protease C1-inhibitor Treatment in Global Market
Table 5. Top Plasma Protease C1-inhibitor Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Plasma Protease C1-inhibitor Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Plasma Protease C1-inhibitor Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Plasma Protease C1-inhibitor Treatment Product Type
Table 9. List of Global Tier 1 Plasma Protease C1-inhibitor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Plasma Protease C1-inhibitor Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Plasma Protease C1-inhibitor Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Plasma Protease C1-inhibitor Treatment Product Offerings
Table 32. Takeda Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2017-2022)
Table 33. CSL Corporate Summary
Table 34. CSL Plasma Protease C1-inhibitor Treatment Product Offerings
Table 35. CSL Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sanquin Corporate Summary
Table 37. Sanquin Plasma Protease C1-inhibitor Treatment Product Offerings
Table 38. Sanquin Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Pharming Group Corporate Summary
Table 40. Pharming Group Plasma Protease C1-inhibitor Treatment Product Offerings
Table 41. Pharming Group Plasma Protease C1-inhibitor Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Plasma Protease C1-inhibitor Treatment Segment by Type in 2021
Figure 2. Plasma Protease C1-inhibitor Treatment Segment by Application in 2021
Figure 3. Global Plasma Protease C1-inhibitor Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Plasma Protease C1-inhibitor Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Plasma Protease C1-inhibitor Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma Protease C1-inhibitor Treatment Revenue in 2021
Figure 8. By Type - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 12. US Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 24. China Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Plasma Protease C1-inhibitor Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Plasma Protease C1-inhibitor Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanquin Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pharming Group Plasma Protease C1-inhibitor Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)